GRPR and neoplasm: This also indicates that, by using the Ga-TacsBOMB2 pharmacophore, the combination of αMe-Trp8 or NMe-Gly11 substitution with Tle10 substitution cannot further improve either the binding affinity to GRPR or increase the uptake in GRPR-expressing PC-3 tumor xenografts.